393 studies found for:    Open Studies | "Multiple Sclerosis"
Show Display Options
Rank Status Study
21 Recruiting ACTH for Fatigue in Multiple Sclerosis Patients
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Drug: ACTH;   Drug: Placebo
22 Unknown  Study Comparing Corpus Callosum Atrophy as a Marker of Later Development of Cognitive Impairment in Patients With Multiple Sclerosis
Conditions: Multiple Sclerosis;   Cognitive Impairment
Intervention:
23 Unknown  The Effects of Aerobics Training on Balance in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Other: Non Impact Aerobics;   Other: Passive : lecture series
24 Unknown  A Safety Study of Combination Treatment With Avonex and Placebo-Controlled Dosing of Topamax in Relapsing-Remitting Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Avonex and Topamax
25 Recruiting EMISEP : Early Spinal Cord Lesions and Late Disability in Relapsing Remitting Multiple Sclerosis Patients
Condition: Multiple Sclerosis
Interventions: Device: spinal cord MRI follow-up;   Other: clinical follow-up;   Other: brain MRI follow-up
26 Recruiting Endpoint Calibration for a Phase 2 Study of Lisinopril in Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Interventions: Procedure: Multiple Sclerosis Functional Composite;   Procedure: Mobile Multiple Sclerosis Functional Composite
27 Recruiting Biologic Basis for Multiple Sclerosis Disease Progression in RRMS Patients Treated With Gilenya
Condition: Multiple Sclerosis-Relapsing-Remitting
Intervention: Drug: Gilenya
28 Unknown  Cognitive Disability and Quality of Life of Patients Suffering From Multiple Sclerosis and Treatment With Immunosuppressant
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Other: Neuropsychological assessment
29 Recruiting A Study of Rebif® in Subjects With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis, Relapsing-Remitting
Intervention: Drug: Rebif®
30 Recruiting Observational Study of Rebismart®2.0 + MSdialog™ in Subjects With Remitting Multiple Sclerosis (ADHERQOL)
Condition: Multiple Sclerosis, Relapsing-remitting
Interventions: Device: RebiSmart®2.0;   Device: MSdialog™
31 Unknown  A Study of MSDx Complex 1 as a Marker for Therapy Response in Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Other: MSDX Complex-1 Biomarker test
32 Not yet recruiting A Study of NeuroVax™, a Novel Therapeutic TCR Peptide Vaccine for SPMS of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: NeuroVax;   Biological: IFA Incomplete Freund's Adjuvant
33 Recruiting Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis
Condition: Secondary Progressive Multiple Sclerosis
Interventions: Biological: MIS416;   Drug: Saline
34 Not yet recruiting Biological Activity and Safety of Low Dose IL2 in Relapsing Remitting Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Intervention: Drug: IL2
35 Recruiting Natural History of Multiple Sclerosis and Its Mimickers
Conditions: Neurologic Disorders;   Healthy Volunteers;   Multiple Sclerosis
Intervention:
36 Recruiting MEsenchymal StEm Cells for Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Mesenchymal stem cells;   Drug: Suspension media
37 Not yet recruiting Proof of Concept Study Evaluating RNS60 in the Treatment of Relapsing Remitting Multiple Sclerosis
Condition: Relapsing Remitting Multiple Sclerosis
Interventions: Drug: RNS60 125 ml;   Drug: RNS60 250 ml;   Drug: Interferon beta 1a
38 Recruiting Multi-Center Study Safety of Adipose Derived Mesenchymal Stem Cells for the Treatment of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Biological: Autologous adipose derived mesenchymal cells
39 Unknown  The Neuroprotective Effect of Lamotrigine and Interferon Beta 1a in Patients With Relapsing-Remitting Multiple Sclerosis
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention: Drug: lamotrigine
40 Recruiting Monitoring Natural Killer Cells in Multiple Sclerosis Patients Treated With Fingolimod
Condition: Relapsing-Remitting Multiple Sclerosis
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years